Learn More
Postmortem studies indicate a loss of nicotinic acetylcholine receptor (nAChRs) in Alzheimer’s disease (AD). In order to establish whether these changes in the cholinergic system occur at an early(More)
Complementing clinical findings with those generated by biomarkers—such as β-amyloid-targeted positron emission tomography (PET) imaging—has been proposed as a means of increasing overall accuracy in(More)